Fedier A - Search Results

1

MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies.

Schwab FD, Scheidmann MC, Ozimski LL, Kling A, Armbrecht L, Ryser T, Krol I, Strittmatter K, Nguyen-Sträuli BD, Jacob F, Fedier A, Heinzelmann-Schwarz V, Wicki A, Dittrich PS, Aceto N. Schwab FD, et al. Among authors: fedier a. Microsyst Nanoeng. 2022 Dec 20;8:130. doi: 10.1038/s41378-022-00467-y. eCollection 2022. Microsyst Nanoeng. 2022. PMID: 36561926 Free PMC article.

2

Suppression of bleb formation, locomotion, and polarity of Walker carcinosarcoma cells by hypertonic media correlates with cell volume reduction but not with changes in the F-actin content.

Fedier A, Keller HU. Fedier A, et al. Cell Motil Cytoskeleton. 1997;37(4):326-37. doi: 10.1002/(SICI)1097-0169(1997)37:4<326::AID-CM4>3.0.CO;2-2. Cell Motil Cytoskeleton. 1997. PMID: 9258505

3

Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light.

Schneider-Yin X, Kurmanaviciene A, Roth M, Roos M, Fedier A, Minder EI, Walt H. Schneider-Yin X, et al. Among authors: fedier a. Photodiagnosis Photodyn Ther. 2009 Mar;6(1):12-8. doi: 10.1016/j.pdpdt.2009.02.001. Epub 2009 Mar 16. Photodiagnosis Photodyn Ther. 2009. PMID: 19447367

4

Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin.

Fedier A, Stuedli A, Fink D. Fedier A, et al. Int J Oncol. 2005 Dec;27(6):1697-705. Int J Oncol. 2005. PMID: 16273226

5

The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.

Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D. Fedier A, et al. Int J Oncol. 2007 Sep;31(3):633-41. Int J Oncol. 2007. PMID: 17671692

6

Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.

von Bueren AO, Bacolod MD, Hagel C, Heinimann K, Fedier A, Kordes U, Pietsch T, Koster J, Grotzer MA, Friedman HS, Marra G, Kool M, Rutkowski S. von Bueren AO, et al. Among authors: fedier a. Br J Cancer. 2012 Oct 9;107(8):1399-408. doi: 10.1038/bjc.2012.403. Epub 2012 Sep 13. Br J Cancer. 2012. PMID: 22976800 Free PMC article.

7

Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.

Fedier A, Erdmann R, Boulikas T, Fink D. Fedier A, et al. Int J Oncol. 2006 Nov;29(5):1303-10. Int J Oncol. 2006. PMID: 17016665

8

MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal.

Fedier A, Poyet C, Perucchini D, Boulikas T, Fink D. Fedier A, et al. Anticancer Drugs. 2006 Mar;17(3):315-23. doi: 10.1097/00001813-200603000-00010. Anticancer Drugs. 2006. PMID: 16520660

9

Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial.

Dedes KJ, Szucs TD, Imesch P, Fedier A, Fehr MK, Fink D. Dedes KJ, et al. Among authors: fedier a. Ann Oncol. 2007 Sep;18(9):1493-9. doi: 10.1093/annonc/mdm185. Ann Oncol. 2007. PMID: 17761705 Free article.

10

Role of p53 and ATM in photodynamic therapy-induced apoptosis.

Heinzelmann-Schwarz V, Fedier A, Hornung R, Walt H, Haller U, Fink D. Heinzelmann-Schwarz V, et al. Among authors: fedier a. Lasers Surg Med. 2003;33(3):182-9. doi: 10.1002/lsm.10213. Lasers Surg Med. 2003. PMID: 12949948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters